Vifor Pharma, Fresenius Kabi create joint venture in China for i.v. iron portfolio

Vifor Pharma has announced a strategic partnership with Fresenius Kabi to create a new joint company based in the People...

February 20, 2020 | Thursday | News
YITU AI Aids Epidemic Prevention and Control of Coronavirus

On February 4th, Shanghai Public Health Clinical Center, one of the authoritative institutions in the field of infectiou...

February 20, 2020 | Thursday | News
DNX Biopharma connects with Lung Cancer Initiative at J&J

US based DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatme...

February 20, 2020 | Thursday | News
Chinese S&T Ministry launches programme to tackle COVID-19

As to the battle against the COVID-19, Chinese Ministry of Science and Technology (MOST) has launched the prog...

February 19, 2020 | Wednesday | News
WuXi Vaccines to build integrated manufacturing facility

WuXi Vaccines, a new vaccine Contract Development and Manufacturing Organization (CDMO) established between WuXi Biologi...

February 18, 2020 | Tuesday | News
WeSure launches coronavirus pneumonia insurance

Following the 2019 novel coronavirus outbreak ("Covid-19"), WeSure, Tencent's insurance platform, swiftly established an...

February 17, 2020 | Monday | News
Hua Medicine appoints former U.S. FDA Officer as CTO

Hua Medicine, a leading clinical stage biotechnology company based in Shanghai,has announced Dr. Fuxing Tang has joined ...

February 17, 2020 | Monday | News
Mathematical model indicates decline in current novel coronavirus infections in China

A mathematical model set up by an ad-hoc group of scientists indicates the number of currently infected novel coronaviru...

February 17, 2020 | Monday | News
PolyU develops most comprehensive multiplex diagnostic system

Infectious diseases represent an important portion of global public health concerns¸ in particular with regard to ...

February 14, 2020 | Friday | News
China's Borui Biomedical imitates Gilead's Coronavirus drug

Borui Bio-Pharmaceutical (Suzhou) Co., Ltd. announced that it has successfully developed and synthesizes the technology ...

February 14, 2020 | Friday | News
WuXi Biologics Wuhan Site Resumes Operations

WuXi Biologics is closely monitoring the coronavirus outbreak.  The firm said its management team is working vigila...

February 14, 2020 | Friday | News
Caution needed in assessing how infectious is coronavirus: GlobalData

One of the most frequently asked questions during the novel 2019 coronavirus (2019-nCoV) outbreak, centered in Wuhan, Ch...

February 12, 2020 | Wednesday | News
Gilead begins trial for coronavirus drug

US based biotech company Gilead is working with health authorities in China to establish a randomized, controlled trial ...

February 12, 2020 | Wednesday | News
Luye Pharma enters into agreement with Cipla Medpro

Luye Pharma Group, with R&D centers in China, the U.S. and Europe, has announced that it has entered into ...

February 11, 2020 | Tuesday | News
BGI opens emergency testing lab for coronavirus

The Huo-Yan Laboratory, an emergency test laboratory run by BGI and designed to handle 10,000 samples daily to detect 20...

February 10, 2020 | Monday | News
Novaerus expands distribution network in China

Novaerus, an Irish company and a part of WellAir that manufactures and sells patented medical-grade, clean air solutions...

February 7, 2020 | Friday | News
Eurofins Discovery, PharmaResources announce commercial cooperation

Eurofins Discovery, the leading provider of services and products to the drug discovery industry, and PharmaResources,&n...

February 5, 2020 | Wednesday | News
Ocumension inks $14M deal with EyePoint Pharma

US based EyePoint Pharmaceuticals, Inc., a biopharmaceutical company committed to developing and commercializing innovat...

February 4, 2020 | Tuesday | News